Leland J. Yee

3.1k total citations
62 papers, 2.3k citations indexed

About

Leland J. Yee is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Leland J. Yee has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 46 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in Leland J. Yee's work include Hepatitis C virus research (45 papers), Hepatitis B Virus Studies (32 papers) and Liver Disease Diagnosis and Treatment (20 papers). Leland J. Yee is often cited by papers focused on Hepatitis C virus research (45 papers), Hepatitis B Virus Studies (32 papers) and Liver Disease Diagnosis and Treatment (20 papers). Leland J. Yee collaborates with scholars based in United States, Canada and United Kingdom. Leland J. Yee's co-authors include Scott D. Rhodes, Kenneth C. Hergenrather, Mark Thursz, Phillip Dinh, Patrick Marcellin, Eduardo B. Martins, Jianming Tang, Ralph J. DiClemente, Marı́a Buti and Scott Fung and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Leland J. Yee

57 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leland J. Yee United States 26 1.5k 1.4k 347 278 201 62 2.3k
J F Peutherer United Kingdom 25 1.4k 1.0× 864 0.6× 1.1k 3.2× 327 1.2× 105 0.5× 60 2.9k
Paul Gibbs United Kingdom 28 669 0.5× 937 0.7× 210 0.6× 324 1.2× 34 0.2× 94 2.7k
Dorine Bresters Netherlands 32 657 0.5× 543 0.4× 191 0.6× 94 0.3× 73 0.4× 124 2.7k
Normand Lapointe Canada 29 1.1k 0.7× 164 0.1× 823 2.4× 375 1.3× 185 0.9× 92 2.3k
A. Gringeri Italy 47 664 0.5× 552 0.4× 503 1.4× 863 3.1× 81 0.4× 175 7.0k
J. J. Goedert United States 20 1.1k 0.7× 842 0.6× 802 2.3× 219 0.8× 47 0.2× 34 2.0k
Suzy Teutsch Australia 17 437 0.3× 310 0.2× 133 0.4× 328 1.2× 76 0.4× 44 979
Agathe León Spain 29 714 0.5× 476 0.4× 1.0k 3.0× 531 1.9× 45 0.2× 79 2.5k
Eva A. Operskalski United States 24 983 0.7× 431 0.3× 816 2.4× 300 1.1× 43 0.2× 42 2.1k
C. R. Rizza United Kingdom 34 888 0.6× 651 0.5× 716 2.1× 974 3.5× 145 0.7× 92 4.8k

Countries citing papers authored by Leland J. Yee

Since Specialization
Citations

This map shows the geographic impact of Leland J. Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leland J. Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leland J. Yee more than expected).

Fields of papers citing papers by Leland J. Yee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leland J. Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leland J. Yee. The network helps show where Leland J. Yee may publish in the future.

Co-authorship network of co-authors of Leland J. Yee

This figure shows the co-authorship network connecting the top 25 collaborators of Leland J. Yee. A scholar is included among the top collaborators of Leland J. Yee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leland J. Yee. Leland J. Yee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Fung, Scott, Calvin Q. Pan, Grace Lai–Hung Wong, et al.. (2023). Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary Pharmacology & Therapeutics. 59(2). 217–229. 7 indexed citations
4.
Lim, Young‐Suk, W. Ray Kim, Douglas T. Dieterich, et al.. (2023). Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses. 15(4). 997–997. 15 indexed citations
5.
Lim, Young‐Suk, Wai‐Kay Seto, Masayuki Kurosaki, et al.. (2022). Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data. Alimentary Pharmacology & Therapeutics. 55(8). 921–943. 19 indexed citations
6.
7.
Buti, Marı́a, Scott Fung, Edward Gane, et al.. (2015). Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. Hepatology International. 9(2). 243–250. 46 indexed citations
8.
Fung, Scott, Stuart C. Gordon, Zahary Krastev, et al.. (2014). Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml). Liver International. 35(2). 422–428. 4 indexed citations
9.
Kim, W. Ray, Thomas Berg, Rohit Loomba, et al.. (2013). 43 LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 58. S19–S19. 28 indexed citations
10.
Rhodes, Scott D., et al.. (2007). Characteristics of a Sample of Men Who Have Sex with Men, Recruited from Gay Bars and Internet Chat Rooms, Who Report Methamphetamine Use. AIDS Patient Care and STDs. 21(8). 575–583. 37 indexed citations
11.
Rhodes, Scott D., Kenneth C. Hergenrather, Leland J. Yee, et al.. (2007). Condom Acquisition and Preferences within a Sample of Sexually Active Gay and Bisexual Men in the Southern United States. AIDS Patient Care and STDs. 21(11). 861–870. 14 indexed citations
12.
Rhodes, Scott D., Kenneth C. Hergenrather, Leland J. Yee, & Bonnie W. Ramsey. (2007). Comparing MSM in the Southeastern United States who participated in an HIV prevention chat room-based outreach intervention and those who did not: how different are the baseline HIV-risk profiles?. Health Education Research. 23(1). 180–190. 16 indexed citations
13.
Yee, Leland J., Sylvia Knapp, David Burgner, et al.. (2004). Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection. Genes and Immunity. 5(3). 183–187. 16 indexed citations
14.
Yee, Leland J.. (2004). Host genetic determinants in hepatitis C virus infection. Genes and Immunity. 5(4). 237–245. 99 indexed citations
15.
Rhodes, Scott D., Leland J. Yee, & Kenneth C. Hergenrather. (2003). Hepatitis A vaccination among young African American men who have sex with men in the deep south: psychosocial predictors.. PubMed. 95(4 Suppl). 31S–36S. 9 indexed citations
16.
Rhodes, Scott D., Kenneth C. Hergenrather, & Leland J. Yee. (2002). Increasing Hepatitis B Vaccination among Young African-American Men Who Have Sex with Men: Simple Answers and Difficult Solutions. AIDS Patient Care and STDs. 16(11). 519–525. 16 indexed citations
17.
Dorak, M. Tevfik, et al.. (2002). C-C Chemokine Receptor 2 and C-C Chemokine Receptor 5 Genotypes in Patients Treated for Chronic Hepatitis C Virus Infection. Immunologic Research. 26(1-3). 167–176. 11 indexed citations
18.
Rhodes, Scott D., Ralph J. DiClemente, Leland J. Yee, & Kenneth C. Hergenrather. (2001). Correlates of hepatitis B vaccination in a high-risk population: an internet sample. The American Journal of Medicine. 110(8). 628–632. 34 indexed citations
19.
20.
Vera, Carlos, et al.. (2000). Tropomodulin-Binding Site Mapped to Residues 7–14 at the N-Terminal Heptad Repeats of Tropomyosin Isoform 5. Archives of Biochemistry and Biophysics. 378(1). 16–24. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J F Peutherer Breakdown of academic impact, for papers by Paul Gibbs Breakdown of academic impact, for papers by Dorine Bresters Breakdown of academic impact, for papers by Normand Lapointe Breakdown of academic impact, for papers by A. Gringeri Breakdown of academic impact, for papers by J. J. Goedert Breakdown of academic impact, for papers by Suzy Teutsch Breakdown of academic impact, for papers by Agathe León Breakdown of academic impact, for papers by Eva A. Operskalski Breakdown of academic impact, for papers by C. R. Rizza
Rankless by CCL
2026